November 17, 2020 — Boston Scientific Corp. announced today it is immediately retiring the entire Lotus Edge ...
Structural Heart
This structural heart channel includes news, videos, podcasts and other content related to diagnosis and treatment of structural heart disease. Topics covered include heart valve repair and replacement, transcatheter aortic valve replacement (TAVR), transcatheter mitral valve replacement (TMVR), transcatheter tricuspid valve replacement (TTVR), left atrial appendage (LAA) occlusion, heart failure interventional device therapies, and closing holes in the heart using, including occlusion of atrial septal defects (ASDs), ventricular septal defects (VSDs) and patent foramen ovales (PFOs).
![Some of the device technologies discussed in the TCT 2020 late-breaking trial sessions. Top left, the Medtronic Resolute Onyx stent was the first stent to receive FDA clearance for short duration dual-antiplatelet therapy, which was a big topic and subject of several sessions. Lower left, the Keystone TriGuard 3 TAVR embolic protection device did not demonstrate superiority over TAVR without use of embolic protection. Top right, the Abbott MitraClip. Acurate neo TAVR valve. #TCTconnect #TCT2020](/sites/default/files/styles/content_feed_large/public/field/image/Screen%20Shot%202020-10-29%20at%2010.31.18%20PM.png?itok=3wGaqGEb)
Here are some of the key takeaways from the late-breaking interventional cardiology and structural heart trials ...
Oct. 29, 2020 — Boston Scientific initiated the CHAMPION-AF clinical trial to evaluate the safety and efficacy of the ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
David Cohen, M.D., presents late-breaking data from the STS/ACC Transcatheter Valve Registry (TVT) showing the impact of ...
Doctor Hans-Josef Feistritzerm, Heart Center of Leipzig, Germany, presents data on the use of general vs. local ...
The late-breaking MitraBridge Study was presented at Transcatheter Cardiovascular Therapeutics (TCT) 2020 meeting showed ...
October 16, 2020 — Positive clinical data from first-in-human studies of the Conformal Medical left atrial appendage ...
October 15, 2020 – The REFLECT II randomized clinical trial evaluating the safety and efficacy of the Keystone Heart ...
![The Boston Scientific Acurate neo self-expanding TAVR valve (left) did not perform as well clinically as the Medtronic CoreValve Evolut TAVR valve (right) in the SCOPE II trial presented at TCT 2020. #TCT #TCT2020 #TCTconnect](/sites/default/files/styles/content_feed_large/public/field/image/Acurate_neo_vs_Corevalve_Evolut_R.jpg?itok=meTwyEE1)
October 15, 2020 – The SCOPE II trial comparing the Boston Scientific Acurate neo vs. Medtronic CoreValve Evolut TAVR ...
October 15, 2020 – The MITHRAS randomized clinical trial found that interventional closure of an iatrogenic atrial ...
October 14, 2020 — The American College of Cardiology (ACC) and the Cardiovascular Research Foundation (CRF) are ...
October 14, 2020 — Medtronic announced it is starting a randomized, head-to-head study comparing two transcatheter ...
![Flexible electronics have been developed to implant in patients to constantly monitor their cardiac condition.](/sites/default/files/styles/content_feed_large/public/field/image/Flexible_conformal_electronics_on_heart.jpg?itok=nUMEpU6n)
This is an overview of some of the biggest cardiology technology advances. These innovations are covered in more detail ...
October 2, 2020 — Cardiac Dimensions announced the company has closed a $17.5 million Series C financing that will be ...
Horst Sievert, M.D., is the director of the Cardiovascular Center Frankfurt, and associate professor of internal ...